Illumina, French Hospitals Partner on Cancer Genomic Profiling Study
The study will compare Illumina's TruSight Oncology 500 assay to the standard of care for therapy selection in up to 400 cancer patients.
Stay updated with breaking news from Seqone Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study will compare Illumina's TruSight Oncology 500 assay to the standard of care for therapy selection in up to 400 cancer patients.
Earlier this week, the tech giant IBM sold off chunks of its once-promising artificial intelligence (AI)-guided division Watson Health. Despite this setback, European firms see a bright future for the use of AI in healthcare.
The French startup targets leadership in personalised medicine with high-performance genomic analysis.
The French company SeqOne Genomics has raised €20M in a Series A round as growing investments reach startups delivering the next generation of genomics and bioinformatics.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!